Common Cold Unit

Last updated

The Common Cold Unit (CCU) or Common Cold Research Unit (CCRU) was a unit of the British Medical Research Council which undertook laboratory and epidemiological research on the common cold between 1946 and 1989 and produced 1,006 papers. [1] The Common cold Unit studied etiology, epidemiology, prevention, and treatment of common colds. [2] It was set up on the site of the Harvard Hospital, a former military hospital at Harnham Down near Salisbury in Wiltshire. Common colds account for a third of all acute respiratory infections [ where? ][ when? ] and the economic costs are substantial in terms of sick leave.

Contents

Thirty volunteers were required every fortnight during trial periods. The unit advertised in newspapers and magazines for volunteers, who were paid a small amount. A stay at the unit was presented in these advertisements as an unusual holiday opportunity. The volunteers were infected with preparations of cold viruses and typically stayed for ten days. They were housed in small groups of two or three, with each group strictly isolated from the others during the course of the stay. Volunteers were allowed to go out for walks in the countryside south of Salisbury, but residential areas were out of bounds.

Human coronaviruses, which are responsible for about 10% of common colds, were first isolated from volunteers at the unit in 1965. The CCU continually recruited volunteers for research into the common cold until its closure in 1990. The final director was David Tyrrell, whose autobiography describes his work at the CCU from 1957.

The CCU was sometimes confused with the Microbiological Research Establishment at nearby Porton Down, a military unit with which it occasionally collaborated but was not officially connected.

History

Our current understanding of colds began in 1914 when Dr. Kruse showed that nasal secretions from people with colds could be filtrated to make them free from bacteria and that inoculation of those filtrated washes into the nose of recipients caused the same illness. Christopher Andrewes and David Tyrrell refined these experiments at Harvard Hospital in Salisbury, England. Around 1946 this hospital became the Common Cold Unit of the Medical Research Council. [3] The Common Cold Research Unit was set up by the Medical Research Council after Dr. Andrewes promoted the idea of researches on volunteers and persuaded authorities to set up the research station. [4] [5]

Discoveries

The first coronavirus (B814) was found in washes from a boy with typical common cold symptoms in 1960 during the study led by virologist David Tyrrell at the Common Cold Unit. After washes were inoculated to volunteers and tested for known viruses none was found. Publication about first human coronavirus was published in The BMJ in 1965. Later virologist June Almeida imaged virus for the first time and group of eight virologists including June Almeida named it coronavirus in their publication in 1968. [6]

Results

For 43 years of Common Cold Unit existence thousands of volunteers participated in researches being inoculated with common cold viruses or being in control group, [7] but no cure for the common cold has been found. [8] Some compounds were active against rhinovirus in vitro, but they didn't demonstrate clinical efficiency. Interferons alpha and beta administered intranasally before virus challenge were effective as prophylactic agents, but they were most effective in prophylaxis rather than treatment and had local side effects so they subsequently were not used in the routine practice against common cold viruses. [8] Research made by the Common Cold Unit improved our understanding of respiratory viruses, their lifecycle and possible vaccines. [9]

Sources

Related Research Articles

<span class="mw-page-title-main">Common cold</span> Common viral infection of the upper respiratory tract

The common cold or the cold is a viral infectious disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx. Signs and symptoms may appear in as little as two days after exposure to the virus. These may include coughing, sore throat, runny nose, sneezing, headache, and fever. People usually recover in seven to ten days, but some symptoms may last up to three weeks. Occasionally, those with other health problems may develop pneumonia.

<span class="mw-page-title-main">Rhinovirus</span> Genus of viruses (Enterovirus)

The rhinovirus is a positive-sense, single-stranded RNA virus belonging to the genus Enterovirus in the family Picornaviridae. Rhinovirus is the most common viral infectious agent in humans and is the predominant cause of the common cold.

<span class="mw-page-title-main">Coronavirus</span> Subfamily of viruses in the family Coronaviridae

Coronaviruses are a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, they cause respiratory tract infections that can range from mild to lethal. Mild illnesses in humans include some cases of the common cold, while more lethal varieties can cause SARS, MERS and COVID-19. In cows and pigs they cause diarrhea, while in mice they cause hepatitis and encephalomyelitis.

<i>Coronaviridae</i> Family of viruses in the order Nidovirales

Coronaviridae is a family of enveloped, positive-strand RNA viruses which infect amphibians, birds, and mammals. Commonly referred to as coronaviruses in the English language, the family coronaviridae includes the subfamilies Letovirinae and Orthocoronavirinae; the latter also known as coronavirinae.

<span class="mw-page-title-main">Respiratory tract infection</span> Infectious disease affecting nose, throat and lungs

Respiratory tract infections (RTIs) are infectious diseases involving the lower or upper respiratory tract. An infection of this type usually is further classified as an upper respiratory tract infection or a lower respiratory tract infection. Lower respiratory infections, such as pneumonia, tend to be far more severe than upper respiratory infections, such as the common cold.

<span class="mw-page-title-main">Human coronavirus NL63</span> Species of virus

Alphacoronavirus amsterdamense is a species of coronavirus, specifically a Setracovirus from among the Alphacoronavirus genus. It was identified in late 2004 in patients in the Netherlands by Lia van der Hoek and Krzysztof Pyrc using a novel virus discovery method VIDISCA. Later on the discovery was confirmed by the researchers from Rotterdam. The virus is an enveloped, positive-sense, single-stranded RNA virus which enters its host cell by binding to ACE2. Infection with the virus has been confirmed worldwide, and has an association with many common symptoms and diseases. Associated diseases include mild to moderate upper respiratory tract infections, severe lower respiratory tract infection, croup and bronchiolitis.

<span class="mw-page-title-main">Christopher Andrewes</span> British virologist (1896–1988)

Sir Christopher Howard Andrewes was a British virologist who discovered the human influenza A virus in 1933.

<span class="mw-page-title-main">MERS-related coronavirus</span> Species of virus

Betacoronavirus cameli, or EMC/2012 (HCoV-EMC/2012), is the virus that causes Middle East respiratory syndrome (MERS). It is a species of coronavirus which infects humans, bats, and camels. The infecting virus is an enveloped, positive-sense, single-stranded RNA virus which enters its host cell by binding to the DPP4 receptor. The species is a member of the genus Betacoronavirus and subgenus Merbecovirus.

<span class="mw-page-title-main">June Almeida</span> Scottish virologist

June Dalziel Almeida was a Scottish virologist, a pioneer in virus imaging and identification. Her skills in electron microscopy earned her an international reputation.

<span class="mw-page-title-main">MERS</span> Viral respiratory infection

Middle East respiratory syndrome (MERS) is a viral respiratory infection caused by Middle East respiratory syndrome–related coronavirus (MERS-CoV). Symptoms may range from none, to mild, to severe depending on age and risk level. Typical symptoms include fever, cough, diarrhea, and shortness of breath. The disease is typically more severe in those with other health problems.

<span class="mw-page-title-main">Human coronavirus HKU1</span> Species of virus

Betacoronavirus hongkonense is a species of coronavirus in humans and animals. It causes an upper respiratory disease with symptoms of the common cold, but can advance to pneumonia and bronchiolitis. It was first discovered in January 2004 from one man in Hong Kong. Subsequent research revealed it has global distribution and earlier genesis.

<span class="mw-page-title-main">Human coronavirus OC43</span> Species of virus

Human coronavirus OC43 (HCoV-OC43) is a member of the species Betacoronavirus 1, which infects humans and cattle. The infecting coronavirus is an enveloped, positive-sense, single-stranded RNA virus that enters its host cell by binding to the N-acetyl-9-O-acetylneuraminic acid receptor. OC43 is one of seven coronaviruses known to infect humans. It is one of the viruses responsible for the common cold and may have been responsible for the 1889–1890 pandemic. It has, like other coronaviruses from genus Betacoronavirus, subgenus Embecovirus, an additional shorter spike protein called hemagglutinin-esterase (HE).

<span class="mw-page-title-main">Human coronavirus 229E</span> Species of virus

Alphacoronavirus chicagoense is a species of coronavirus which infects humans and bats. It is an enveloped, positive-sense, single-stranded RNA virus which enters its host cell by binding to the APN receptor. Along with Human coronavirus OC43, it is one of the viruses responsible for the common cold. HCoV-229E is a member of the genus Alphacoronavirus and subgenus Duvinacovirus.

David Arthur John Tyrrell was a British virologist who was the director of the Common Cold Unit, which investigated viruses that caused common colds. He discovered the first human coronavirus in 1965. With June Almeida he made the first comparative study of human and chicken coronaviruses in 1967, and invented the name coronavirus in 1968.

<span class="mw-page-title-main">Hélio Gelli Pereira</span> Brazilian-British virologist

Hélio Gelli Pereira was a Brazilian-British virologist specialising in adenoviruses. Pereira was a co-recipient of the 1988 UNESCO Carlos J. Finlay Prize for Microbiology and was known for his work on the book, Viruses of Vertebrates. He contributed to several areas of virology in research and international public service.

<span class="mw-page-title-main">Coronavirus diseases</span> List of Coronavirus diseases

Coronavirus diseases are caused by viruses in the coronavirus subfamily, a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, the group of viruses cause respiratory tract infections that can range from mild to lethal. Mild illnesses in humans include some cases of the common cold, while more lethal varieties can cause SARS, MERS and COVID-19. As of 2021, 45 species are registered as coronaviruses, whilst 11 diseases have been identified, as listed below.

<span class="mw-page-title-main">COVID-19</span> Contagious disease caused by SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. Most scientists believe the SARS-CoV-2 virus entered into human populations through natural zoonosis, similar to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Social and environmental factors including climate change, natural ecosystem destruction and wildlife trade increased the likelihood of such zoonotic spillover. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.

<span class="mw-page-title-main">GC376</span> Broad-spectrum antiviral medication

GC376 is a broad-spectrum antiviral medication under development by the biopharmaceutical company Anivive Lifesciences for therapeutic uses in humans and animals. Anivive licensed the exclusive worldwide patent rights to GC376 from Kansas State University. As of 2020, GC376 is being investigated as a treatment for COVID-19. GC376 shows activity against many human and animal viruses, including coronavirus and norovirus; the most extensive research has been multiple in vivo studies in cats treating a coronavirus, which causes deadly feline infectious peritonitis. Other research supports use in porcine epidemic diarrhea virus.

The treatment and management of COVID-19 combines both supportive care, which includes treatment to relieve symptoms, fluid therapy, oxygen support as needed, and a growing list of approved medications. Highly effective vaccines have reduced mortality related to SARS-CoV-2; however, for those awaiting vaccination, as well as for the estimated millions of immunocompromised persons who are unlikely to respond robustly to vaccination, treatment remains important. Some people may experience persistent symptoms or disability after recovery from the infection, known as long COVID, but there is still limited information on the best management and rehabilitation for this condition.

<span class="mw-page-title-main">History of coronavirus</span> History of the virus group

The history of coronaviruses is an account of the discovery of the diseases caused by coronaviruses and the diseases they cause. It starts with the first report of a new type of upper-respiratory tract disease among chickens in North Dakota, U.S., in 1931. The causative agent was identified as a virus in 1933. By 1936, the disease and the virus were recognised as unique from other viral disease. They became known as infectious bronchitis virus (IBV), but later officially renamed as Avian coronavirus.

References

  1. ↑ Oransky, Ivan (18 June 2005). "David Tyrrell, Obituary". The Lancet. 365 (9477): 2084. doi:10.1016/S0140-6736(05)66722-0. PMID   16121448. S2CID   43188254. Archived from the original (PDF) on 28 August 2021.
  2. ↑ Halstead, Scott B. (9 April 2020). "An Urgent Need for "Common Cold Units" to Study COVID-19". The American Journal of Tropical Medicine and Hygiene. 102 (6): 1152–1153. doi:10.4269/ajtmh.20-0246. ISSN   0002-9637. PMC   7253108 . PMID   32274988.
  3. ↑ Lorber, Bennett (April 1996). "The common cold". Journal of General Internal Medicine. 11 (4): 229–236. doi:10.1007/BF02642480. ISSN   0884-8734. PMC   7089473 . PMID   8744881.
  4. ↑ "Andrewes, Sir Christopher Howard (1896–1988), virologist" . Oxford Dictionary of National Biography (online ed.). Oxford University Press. 23 September 2004. doi:10.1093/ref:odnb/40059. ISBN   978-0-19-861412-8. Archived from the original on 18 September 2021. Retrieved 18 September 2021.(Subscription or UK public library membership required.)
  5. ↑ Tyrrell, D. A. (July 1987). "The common cold--my favourite infection. The eighteenth Majority Stephenson memorial lecture". The Journal of General Virology. 68 ( Pt 8) (8): 2053–2061. doi: 10.1099/0022-1317-68-8-2053 . ISSN   0022-1317. PMID   3039038.
  6. ↑ Mahase, Elisabeth (16 April 2020). "Covid-19: Coronavirus was first described in The BMJ in 1965". BMJ (Clinical Research Ed.). 369: m1547. doi: 10.1136/bmj.m1547 . ISSN   1756-1833. PMID   32299810. Archived from the original (PDF) on 28 August 2021.
  7. ↑ Ellis, Harold (4 January 2003). "Cold Wars: The Fight against the Common Cold". BMJ: British Medical Journal. 326 (7379): 57. doi:10.1136/bmj.326.7379.57/a. ISSN   0959-8138. PMC   1124964 .
  8. 1 2 Snell, N. J. C. (March 2001). "New treatments for viral respiratory tract infections—opportunities and problems". Journal of Antimicrobial Chemotherapy. 47 (3): 251–259. doi:10.1093/jac/47.3.251. ISSN   0305-7453. PMC   7110210 . PMID   11222557.
  9. ↑ Lambkin-Williams, Rob; Noulin, Nicolas; Mann, Alex; Catchpole, Andrew; Gilbert, Anthony S. (22 June 2018). "The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics". Respiratory Research. 19 (1): 123. doi: 10.1186/s12931-018-0784-1 . ISSN   1465-993X. PMC   6013893 . PMID   29929556.

51°3′12″N1°48′8″W / 51.05333°N 1.80222°W / 51.05333; -1.80222

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.